AbbVie does T cell engager deal in China for Zelgen’s DLL3-targeted drug
Title: AbbVie Strikes T cell Engager Deal with Zelgen for DLL3-targeted Drug Publication Date: December 31, 2025 In the waning days of 2025, Chicago-based pharmaceutical titan AbbVie announced another strategic alliance in China, reaffirming its commitment to expanding its oncology…